198 related articles for article (PubMed ID: 8552823)
21. Value of sonography in monitoring the therapeutic response of mediastinal lymphoma: comparison with chest radiography and CT.
Wernecke K; Vassallo P; Hoffmann G; Peters PE; Poetter R; Rummeny E; Koch P
AJR Am J Roentgenol; 1991 Feb; 156(2):265-72. PubMed ID: 1898797
[TBL] [Abstract][Full Text] [Related]
22. MRI of anterior mediastinal tumors.
Ikezoe J; Takeuchi N; Johkoh T; Kohno N; Takashima S; Tomiyama N; Arisawa J; Yamagami H; Yoshioka H; Higashihara T
Radiat Med; 1992; 10(5):176-83. PubMed ID: 1438925
[TBL] [Abstract][Full Text] [Related]
23. A comparison of gallium-67 single photon emission computed tomography and computed tomography in mediastinal Hodgkin's disease.
Karimjee S; Brada M; Husband J; McCready VR
Eur J Cancer; 1992; 28A(11):1856-7. PubMed ID: 1389526
[TBL] [Abstract][Full Text] [Related]
24. Comparison of (18)F Flurodeoxyglucose PET with Ga-67 scintigraphy and conventional imaging modalities in pediatric lymphoma.
Mody RJ; Bui C; Hutchinson RJ; Frey KA; Shulkin BL
Leuk Lymphoma; 2007 Apr; 48(4):699-707. PubMed ID: 17454627
[TBL] [Abstract][Full Text] [Related]
25. Long-term follow-up of residual mediastinal-hilar Ga-67 uptake after treatment for Hodgkin's and non-Hodgkin's lymphomas: what degree of Ga-67 uptake is significant?
Nikpoor N; Aliabadi P; Diaz L; Mannting F
Clin Nucl Med; 2000 Dec; 25(12):959-62. PubMed ID: 11129161
[TBL] [Abstract][Full Text] [Related]
26. Gallium-67 scintigraphy in lymphoma: is there a benefit of image fusion with computed tomography?
Chajari M; Lacroix J; Peny AM; Chesnay E; Batalla A; Henry-Amar M; Delcambre C; Génot JY; Fruchard C; Bardet S
Eur J Nucl Med Mol Imaging; 2002 Mar; 29(3):380-7. PubMed ID: 12002715
[TBL] [Abstract][Full Text] [Related]
27. Role of magnetic resonance imaging in predicting relapse in residual masses after treatment of lymphoma.
Hill M; Cunningham D; MacVicar D; Roldan A; Husband J; McCready R; Mansi J; Milan S; Hickish T
J Clin Oncol; 1993 Nov; 11(11):2273-8. PubMed ID: 8229142
[TBL] [Abstract][Full Text] [Related]
28. Negative predictive value of gallium-67 SPET/CT in a case of Hodgkin's lymphoma with bulky mediastinal disease.
Harisankar CN; Kamaleshwaran KK; Bhattacharya A; Singh B; Mittal BR
Hell J Nucl Med; 2009; 12(1):64-5. PubMed ID: 19330188
[No Abstract] [Full Text] [Related]
29. [Magnetic resonance in the evaluation of mediastinal masses].
Gualdi GF; Caterino M; Polettini E; Ceroni L
Radiol Med; 1990; 80(1-2):36-9. PubMed ID: 2217941
[TBL] [Abstract][Full Text] [Related]
30. Clinical relevance of gallium-67 scintigraphy in lymphoma before and after therapy.
Delcambre C; Reman O; Henry-Amar M; Peny AM; Macro M; Cheze S; Génot JY; Tanguy A; Switsers O; Van HL; Couëtte JE; Leporrier M; Bardet S
Eur J Nucl Med; 2000 Feb; 27(2):176-84. PubMed ID: 10755723
[TBL] [Abstract][Full Text] [Related]
31. Lymphoma: evaluation with Ga-67 SPECT.
Tumeh SS; Rosenthal DS; Kaplan WD; English RJ; Holman BL
Radiology; 1987 Jul; 164(1):111-4. PubMed ID: 3495815
[TBL] [Abstract][Full Text] [Related]
32. Surgical approach to isolated mediastinal lymphoma.
Ricci C; Rendina EA; Venuta F; Pescarmona EO; Di Tolla R; Ruco LP; Guglielmi C; Anselmo AP; Mandelli F
J Thorac Cardiovasc Surg; 1990 Apr; 99(4):691-5. PubMed ID: 2319792
[TBL] [Abstract][Full Text] [Related]
33. Mediastinal Hodgkin disease in children: response to therapy.
Luker GD; Siegel MJ
Radiology; 1993 Dec; 189(3):737-40. PubMed ID: 8234698
[TBL] [Abstract][Full Text] [Related]
34. Discrepancies and priorities in staging and restaging malignant lymphoma by SPET, SPET/CT, PET/CT and PET/MRI.
Chavdarova LI; Tzonevska AD; Piperkova EN
Hell J Nucl Med; 2013; 16(3):223-9. PubMed ID: 24137584
[TBL] [Abstract][Full Text] [Related]
35. MRI characterization of residual mediastinal masses in Hodgkin's disease: long-term follow-up.
Di Cesare E; Cerone G; Enrici RM; Tombolini V; Anselmo P; Masciocchi C
Magn Reson Imaging; 2004 Jan; 22(1):31-8. PubMed ID: 14972392
[TBL] [Abstract][Full Text] [Related]
36. Hodgkin disease: use of Tl-201 to monitor mediastinal involvement after treatment.
Fletcher BD; Xiong X; Kauffman WM; Kaste SC; Hudson MM
Radiology; 1998 Nov; 209(2):471-5. PubMed ID: 9807576
[TBL] [Abstract][Full Text] [Related]
37. Mediastinal tumors: sensitivity of detection with sonography compared with CT and radiography.
Wernecke K; Vassallo P; Pötter R; Lückener HG; Peters PE
Radiology; 1990 Apr; 175(1):137-43. PubMed ID: 2179987
[TBL] [Abstract][Full Text] [Related]
38. Validation of gallium-67-citrate single-photon emission computed tomography in biopsy-confirmed residual Hodgkin's disease in the mediastinum.
Kostakoglu L; Yeh SD; Portlock C; Heelan R; Yao TJ; Niedzwiecki D; Larson SM
J Nucl Med; 1992 Mar; 33(3):345-50. PubMed ID: 1740700
[TBL] [Abstract][Full Text] [Related]
39. Mediastinal lymphoma: quantitative changes in gadolinium enhancement at MR imaging after treatment.
Rahmouni A; Divine M; Lepage E; Jazaerli N; Belhadj K; Gaulard P; Golli M; Reyes F; Vasile N
Radiology; 2001 Jun; 219(3):621-8. PubMed ID: 11376245
[TBL] [Abstract][Full Text] [Related]
40. [Malignant lymphoma: magnetic resonance tomography findings in residual supradiaphragmatic space-occupying lesions].
Stroszczynski C; Hosten N; Oellinger J; Spahn G; Amthauer H; Bittner RC; Hierholzer J; Ludwig WD; Felix R
Rofo; 1999 Sep; 171(3):192-9. PubMed ID: 10520328
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
